4073 Results

People

  1. Hudis
    Hudis
  2. Giralt
    Giralt
  3. Gonen
    Gonen
  4. Levine
    Levine
  5. Scher
    Scher
  6. Fong
    Fong
  7. Motzer
    Motzer
  8. Ladanyi
    Ladanyi
  9. Travis
    Travis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)
  7. Department of Pathology and Laboratory Medicine (556)
  8. Center for Hematologic Malignancies (550)
  9. Hematologic Malignancies, Division of (465)
  10. Epidemiology and Biostatistics (464)
  1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tet2 loss accelerates the myeloproliferative neoplasm (MPN) phenotype of Jak2V617F knockin mice but is insufficient to cause leukemic transformation
    Meeting Abstract

    Chen, E.; Breyfogle, L. J.; Schneider, R. K.; Poveromo, L.; Levine, R. L.; Ebert, B. L.; Mullally, A.
    Blood (2013)

    Fulltext@MSK | Save
  • High-throughput mutational profiling of post-myeloproliferative neoplasm acute myeloid leukemia reveals frequent mutations in NRAS in JAK2V617F-negative post-MPN AML
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; McKenney, A. S.; Knapp, K. M.; Patel, M.; Wang, K.; Nahas, M. K.; Yelensky, R.; Otto, G. A.; Lipson, D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Predicting therapy-related acute myeloid leukemia by routine laboratory values: An analysis Of 126 patients with breast cancer referred for bone marrow biopsy at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Stein, E. M.; Hsu, M.; Goldrich, A.; Kishtagari, A.; Devlin, S. M.; Tallman, M. S.; Soff, G. A.; Parameswaran, R.
    Blood (2013)

    Fulltext@MSK | Save
  • A high complete remission rate can be achieved in older patients (age >= 60) with acute lymphoblastic leukemia regardless of induction intensities: Single-institution experience at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Park, J. H.; Lee, S.; Devlin, S. M.; Tallman, M. S.; Douer, D.
    Blood (2013)

    Fulltext@MSK | Save
  • Frontline-treatment of acute lymphoblastic leukemia (ALL) in older adolescents and young adults (AYA) using a pediatric regimen is feasible: Toxicity results of the prospective US Intergroup Trial C10403 (Alliance)
    Meeting Abstract

    Advani, A. S.; Sanford, B.; Luger, S.; Devidas, M.; Larsen, E. C.; Liedtke, M.; Voorhees, P. M.; Foster, M. C.; Claxton, D. F.; Geyer, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The number of peg-asparaginase doses administered is a determinant of relapse risk in adult ALL treated with a pediatric-like regimen
    Meeting Abstract

    Aldoss, I.; Pullarkat, V.; Martinez, D.; Ji, L.; Douer, D.
    Blood (2013)

    Fulltext@MSK | Save
  • Single-arm, open-label, multicenter study of deep molecular response (MR(4.5)) with nilotinib in adult patients (pts) with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (CML-CP): ENESTnext study update
    Meeting Abstract

    Mauro, M.; Radich, J.; Cortes, J. E.; Dakhil, S.; Keir, C.; Yi, S.; Wadleigh, M.; Oehler, V. G.; Ervin, T.; Goldberg, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Inhibition of LSD1 as a therapeutic strategy for the treatment of acute myeloid leukemia
    Meeting Abstract

    Kruger, R. G.; Mohammad, H.; Smitheman, K.; Cusan, M.; Liu, Y.; Pappalardi, M.; Federowicz, K.; Van Aller, G.; Kasparec, J.; Tian, X.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Prevention of minimal residual disease in Ph+ ALL
    Meeting Abstract

    Appelmann, I.; DeStanchina, E.; Carbonetti, G.; Chen, C.; Lowe, S. W.; Sherr, C. J.
    Blood (2013)

    Fulltext@MSK | Save
  • Romidepsin is effective and well-tolerated in patients >= 60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): Analysis from phase 2 trials
    Meeting Abstract

    Shustov, A. R.; Coiffier, B.; Horwitz, S. M.; Sokol, L.; Pro, B.; Nielsen, T.; Wolfson, J.; Balser, B. E.; Eisch, R.; Popplewell, L.; more...
    Blood (2013)

    Fulltext@MSK | Save